No abstract available
MeSH terms
-
Animals
-
Antineoplastic Agents / pharmacology*
-
Benzamides
-
Drug Resistance, Neoplasm
-
Enzyme Inhibitors / pharmacology
-
Fusion Proteins, bcr-abl / drug effects*
-
Fusion Proteins, bcr-abl / metabolism
-
Humans
-
Imatinib Mesylate
-
Leukemia, Myelogenous, Chronic, BCR-ABL Positive / drug therapy*
-
Leukemia, Myelogenous, Chronic, BCR-ABL Positive / metabolism
-
Orosomucoid / drug effects*
-
Orosomucoid / metabolism*
-
Piperazines / pharmacology*
-
Protein-Tyrosine Kinases / antagonists & inhibitors*
-
Protein-Tyrosine Kinases / genetics
-
Pyrimidines / pharmacology*
Substances
-
Antineoplastic Agents
-
Benzamides
-
Enzyme Inhibitors
-
Orosomucoid
-
Piperazines
-
Pyrimidines
-
Imatinib Mesylate
-
Protein-Tyrosine Kinases
-
Fusion Proteins, bcr-abl